Sentinel lymph nodes with technetium-99m colloidal rhenium sulfide in patients with esophageal carcinoma

Cancer

Volumn 98, Issue 5, 2003, Pages 932-939

  Kato, Hiroyuki ^a   Miyazaki, Tatsuya ^a   Nakajima, Masanobu ^a   Takita, Junko ^a   Sohda, Makoto ^a   Fukai, Yasuyuki ^a   Masuda, Norihiro ^a   Fukuchi, Minoru ^a   Manda, Ryokuhei ^a   Ojima, Hitoshi ^a   Tsukada, Katsuhiko ^a   Asao, Takayuki ^a   Kuwano, Hiroyuki ^a   Oriuchi, Noboru ^a   Endo, Keigo ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

Cytokeratin immunostaining; Esophageal squamous cell carcinoma; Occult metastasis; Rhenium sulfide; Sentinel lymph node

Indexed keywords

CYTOKERATIN; NANOCIS; RHENIUM TECHNETIUM TC 99M;

ADULT; AGED; ARTICLE; CANCER SCINTISCANNING; CANCER STAGING; CLINICAL ARTICLE; ESOPHAGUS CARCINOMA; ESOPHAGUS RESECTION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; LYMPHADENECTOMY; LYMPHATIC MAPPING; LYMPHATIC SYSTEM; LYMPHOSCINTIGRAPHY; MALE; OCCULT CANCER; PRIORITY JOURNAL; SENTINEL LYMPH NODE; SQUAMOUS CELL CARCINOMA;

AGED; CARCINOMA; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FALSE NEGATIVE REACTIONS; FEMALE; HUMANS; IMMUNOCHEMISTRY; KERATINS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; RADIOPHARMACEUTICALS; RHENIUM; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY; TECHNETIUM COMPOUNDS;

EID: 0042388463     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.11559     Document Type: Article

References (41)

1. Albertini JJ, Lyman GH, Cox C, et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA. 1996;276:1818-1822.
2. Stewart KC, Lyster DM. Interstitial lymphoscintigraphy for lymphatic mapping in surgical practice and research. J Invest Surg. 1997;10:249-262.
3. Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg. 1992;127:392-399.
4. Krag DN, Weaver DL, Alex JC, et al. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol. 1993;2:335-339.
5. Wells KE, Rapaport DP, Cruse CW, et al. Sentinel lymph node biopsy in melanoma of the head and neck. Plast Reconstr Surg. 1997;100:591-594.
6. Kelemen PR, Van Herle AJ, Giuliano AE. Sentinel lymphadenectomy in thyroid malignant neoplasms. Arch Surg. 1998;133:288-292.
7. Giuliano AE, Kirgan DM, Guenther JM, et al. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg. 1994;220:391-401.
8. Giuliano AE, Dale PS, Turner RR, et al. Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg. 1995;222:394-401.
9. Giuliano AE, Jones RC, Brennan M, et al. Sentinel lymphadenectomy in breast cancer. J Clin Oncol. 1997;15:2345-2350.
10. Noguchi M, Tsugawa K, Kawahara F, et al. Dye-guided sentinel lymphadenectomy in clinically node-negative and node-positive breast cancer patients. Breast Cancer. 1998;5:381-387.
11. Flett MM, Going JJ, Stanton PD, et al. Sentinel node localization in patients with breast cancer. Br J Surg. 1998;85:991-993,
12. Guenther JM, Krishnamoorthy M, Tan LR. Sentinel lymphadenectomy for breast cancer in a community managed care setting. Cancer J Sci Am. 1997;3:336-340.
13. Dale PS, Williams JT IV. Axillary staging utilizing selective sentinel lymphadenectomy for patients with invasive breast carcinoma. Am Surg. 1998;64:28-32.
14. Koller M, Barsuk D, Zippel D, et al. Sentinel lymph node involvement - a predictor for axillary node status with breast cancer - has the time come? Eur J Surg Oncol. 1998;24:166-168.
15. Veronesi U, Paganelli G, Galimberti V, et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet. 1997;349:1864-1867.
16. Pijpers R, Meijer S, Hoekstra OS, et al. Impact of lymphoscintigraphy on sentinel node identification with technetium-99m-colloidal albumin in breast cancer. J Nucl Med. 1997;38:366-368.
17. Borgstein PJ, Pijpers R, Comans EF, et al. Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. J Am Coll Surg. 1998;186:275-283.
18. Miner TJ, Shriver CD, Jaques DP, et al. Ultrasonographically guided injection improves localization of the radiolabeled sentinel lymph node in breast cancer. Ann Surg Oncol. 1998;5:315-321.
19. Crossin JA, Johnson AC, Stewart PB, et al. Gamma-probe-guided resection of the sentinel lymph node in breast cancer. Am Surg. 1998;64:666-669.
20. Krag D, Weaver D, Ashikaga T, et al. The sentinel node in breast cancer - a multicenter validation study. N Engl J Med. 1998;339:941-946.
21. Watanabe T, Kimijima I, Ohtake T, et al. Sentinel node biopsy with technetium-99m colloidal rhenium sulphide in patients with breast cancer. Br J Surg. 2001;88:704-707.
22. Offodile R, Hoh C, Barsky SH, et al. Minimally invasive breast carcinoma staging using lymphatic mapping with radiolabeled dextran. Cancer. 1998;82:1704-1708.
23. Barnwell JM, Arredondo MA, Kollmorgen D, et al. Sentinel node biopsy in breast cancer. Ann Surg Oncol. 1998;5:126-130.
24. O'Hea BJ, Hill AD, El-Shirbiny AM, et al. Sentinel lymph node biopsy in breast cancer: initial experience at Memorial Sloan-Kettering Cancer Center. J Am Coll Surg. 1998;186:423-427.
25. Smillie T, Hayashi A, Rusnak C, et al. Evaluation of feasibility and accuracy of sentinel node biopsy in early breast cancer. Am J Surg. 2001;181:427-430.
26. Imoto S, Fukukita H, Murakami K, et al. Pilot study on sentinel node biopsy in breast cancer. J Surg Oncol. 2000;73:130-133.
27. Cox CE, Pendas S, Cox JM, et al. Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg. 1998;227:645-653.
28. Pendas S, Dauway E, Cox CE, et al. Sentinel node biopsy and cytokeratin staining for the accurate staging of 478 breast cancer patients. Am Surg. 1999;65:500-506.
29. Branagan G, Hughes D, Jeffrey M, et al. Detection of micrometastases in lymph nodes from patients with breast cancer. Br J Surg. 2002;89:86-89.
30. Kitagawa Y, Ohgami M, Fujii H, et al. Laparoscopic detection of sentinel lymph nodes in gastrointestinal cancer: a novel and minimally invasive approach. Ann Surg Oncol. 2001;8:86S-89S.
31. Japanese Society for Esophageal Diseases. Guidelines for the clinical and pathological studies on carcinoma of the esophagus, 9th edition. Tokyo: Kanehara, 1999.
32. Beck JR. Likelihood ratios. Another enhancement of sensitivity and specificity. Arch Pathol Lab Med. 1986;110:685-686.
33. Wood TF, Tsioulias GJ, Morton DL, et al. Focused examination of sentinel lymph nodes upstages early colorectal carcinoma. Am Surg. 2000;66:998-1003.
34. Tsioulias GJ, Wood TF, Morton DL, et al. Lymphatic mapping and focused analysis of sentinel lymph nodes upstage gastrointestinal neoplasms. Arch Surg. 2000;135:926-932.
35. Waters GS, Geisinger KR, Garske DD, et al. Sentinel lymph node mapping for carcinoma of the colon: a pilot study. Am Surg. 2000;66:943-945.
36. Kitagawa Y, Fujii H, Mukai M, et al. The role of the sentinel lymph node in gastrointestinal cancer. Surg Clin North Am. 2000;80:1799-1809.
37. Yasuda S, Shimada H, Chino O, et al. Sentinel lymph node detection with Tc-99m tin colloids in patients with esophagogastric cancer. Jpn J Clin Oncol. 2003;33:68-72.
38. De Cicco C, Cremonesi M, Luini A, et al. Lymphoscintigraphy and radioguided biopsy of the sentinel axillary node in breast cancer. J Nucl Med. 1998;39:2080-2084.
39. Molpus KL, Kelley MC, Johnson JE, et al. Sentinel lymph node detection and microstaging in vulvar carcinoma. J Reprod Med. 2001;46:863-869.
40. Hosch SB, Stoecklein NH, Pichlmeier U, et al. Esophageal cancer: the mode of lymphatic tumor cell spread and its prognostic significance. J Clin Oncol. 2001;19:1970-1975.
41. Bilchik AJ, Saha S, Wiese D, et al. Molecular staging of early colon cancer on the basis of sentinel node analysis: a multicenter Phase II trial. J Clin Oncol. 2001;19:1128-1136.